Six things to know about the executive orders:
1. The first will require federally qualified health centers to pass discounts on insulin and EpiPens directly to patients.
2. The second order will allow states, wholesalers and pharmacies to import FDA-approved drugs from Canada and other countries where the drug price is significantly lower.
3. The third would direct drug rebates to patients in an effort to simplify the system.
4. It is unclear when orders 1-3 will be finalized and take effect.
5. The fourth, more sweeping order will require Medicare to purchase drugs at the same price paid by other economically advanced countries.
6. President Trump will delay the implementation of the fourth order until Aug. 24 to give pharmaceutical executives, who strongly oppose the idea, a chance to propose an alternative. The president said he will meet with drug company executives at the White House on Tuesday.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.